286 related articles for article (PubMed ID: 22097611)
21. Seroprevalence of Toxoplasma gondii, cytomegalovirus, rubella virus and Chlamydia trachomatis among infertile women attending in vitro fertilization center, Gaza strip, Palestine.
Al-Hindi A; Al-Helou T; Al-Helou Y
J Egypt Soc Parasitol; 2010 Aug; 40(2):451-8. PubMed ID: 21246952
[TBL] [Abstract][Full Text] [Related]
22. Serological evidence of Toxoplasma gondii infection among pregnant women in Auckland.
Morris A; Croxson M
N Z Med J; 2004 Feb; 117(1189):U770. PubMed ID: 15014559
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis of recent primary rubella virus infections: significance of glycoprotein-based IgM serology, IgG avidity and immunoblot analysis.
Wandinger KP; Saschenbrecker S; Steinhagen K; Scheper T; Meyer W; Bartelt U; Enders G
J Virol Methods; 2011 Jun; 174(1-2):85-93. PubMed ID: 21513745
[TBL] [Abstract][Full Text] [Related]
24. [Determination of cytomegalo-, herpes simplex- and rubellavirus-antibodies resp. during perinatal period by Elisa-technique (author's transl)].
Dennin RH; Husstedt W
Geburtshilfe Frauenheilkd; 1982 May; 42(5):357-60. PubMed ID: 6286403
[TBL] [Abstract][Full Text] [Related]
25. The Screening of
Nabizadeh E; Ghotaslou A; Salahi B; Ghotaslou R
Infect Dis Obstet Gynecol; 2022; 2022():4490728. PubMed ID: 35046632
[TBL] [Abstract][Full Text] [Related]
26. Possible role of TORCH agents in congenital malformations in Gorgan, northern Islamic Republic of Iran.
Golalipour MJ; Khodabakhshi B; Ghaemi E
East Mediterr Health J; 2009; 15(2):330-6. PubMed ID: 19554979
[TBL] [Abstract][Full Text] [Related]
27. Serological screening for antenatal toxoplasma infection in India.
Khurana S; Bagga R; Aggarwal A; Lyngdoh V; ; Diddi K; Malla N
Indian J Med Microbiol; 2010; 28(2):143-6. PubMed ID: 20404461
[TBL] [Abstract][Full Text] [Related]
28. [Seroprevalence rates of Toxoplasma gondii, rubella, cytomegalovirus, syphilis, and hepatitis B, seroprevalences rate in the pregnant population in İstanbul].
Doğan K; Güraslan H; Özel G; Aydan Z; Yaşar L
Turkiye Parazitol Derg; 2014 Dec; 38(4):228-33. PubMed ID: 25732880
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of antibodies to rubella, herpes simplex 2 and cytomegalovirus in pregnant women and in neonates at Ga-Rankuwa.
Bos P; Steele D; Alexander J
Cent Afr J Med; 1995 Jan; 41(1):14-7. PubMed ID: 7767930
[TBL] [Abstract][Full Text] [Related]
30. Investigation of congenital infection--the TORCH screen is not a legitimate test. Paediatric Infectious Diseases Group of the Australasian Society for Infectious Diseases.
Garland SM; Gilbert GL
Med J Aust; 1993 Sep; 159(5):346-8. PubMed ID: 8395645
[No Abstract] [Full Text] [Related]
31. Antibodies to rubellavirus, herpes simplex virus and Toxoplasma gondii in serial serum samples of pregnant and non-pregnant women.
Pácsa AS; Pejtsik B
Acta Microbiol Acad Sci Hung; 1978; 25(3):203-7. PubMed ID: 211807
[TBL] [Abstract][Full Text] [Related]
32. Significance of avidity and immunoblot analysis for rubella IgM-positive serum samples in pregnant women.
Hofmann J; Liebert UG
J Virol Methods; 2005 Dec; 130(1-2):66-71. PubMed ID: 16024097
[TBL] [Abstract][Full Text] [Related]
33. Infectious antibodies in systemic lupus erythematosus patients.
Berkun Y; Zandman-Goddard G; Barzilai O; Boaz M; Sherer Y; Larida B; Blank M; Anaya JM; Shoenfeld Y
Lupus; 2009 Nov; 18(13):1129-35. PubMed ID: 19880558
[TBL] [Abstract][Full Text] [Related]
34. [Distribution of HSV-1 and HSV-2 antibodies in pregnant women].
Arseven G; Tuncel E; Tuncel S; Sönmez E; Gülen AK
Mikrobiyol Bul; 1992 Oct; 26(4):359-66. PubMed ID: 1331720
[TBL] [Abstract][Full Text] [Related]
35. Seroprevalence of TORCH infections in women of childbearing age in Croatia.
Vilibic-Cavlek T; Ljubin-Sternak S; Ban M; Kolaric B; Sviben M; Mlinaric-Galinovic G
J Matern Fetal Neonatal Med; 2011 Feb; 24(2):280-3. PubMed ID: 20476874
[TBL] [Abstract][Full Text] [Related]
36. Performance of the immunoglobulin G avidity and enzyme immunoassay IgG/IgM screening tests for differentiation of the clinical spectrum of toxoplasmosis.
Tanyuksel M; Guney C; Araz E; Saracli MA; Doganci L
J Microbiol; 2004 Sep; 42(3):211-5. PubMed ID: 15459650
[TBL] [Abstract][Full Text] [Related]
37. Sero-epidemiology of TORCH agents among pregnant Thais.
Puthavathana P; Pimolpan K; Louisirirotchanakul S; Wasi C; Thongcharoen P
Asian Pac J Allergy Immunol; 1983 Jun; 1(1):11-4. PubMed ID: 6099729
[No Abstract] [Full Text] [Related]
38. Seroprevalence to some TORCH agents in a Sicilian female population of fertile age.
Condorelli F; Scalia G; Stivala A; Costanzo MC; Adragna AD; Franceschino C; Santagati MG; Furneri PM; Marino A; Castro A
Eur J Epidemiol; 1993 May; 9(3):341-3. PubMed ID: 8405322
[TBL] [Abstract][Full Text] [Related]
39. Improvement of cytomegalovirus avidity testing by adjusting the concentration of CMV-specific IgG in test samples.
Dangel V; Bäder U; Enders G
J Clin Virol; 2006 Mar; 35(3):303-9. PubMed ID: 16298547
[TBL] [Abstract][Full Text] [Related]
40. Infectious immune status in an obstetric population of Pakistani immigrants in Norway.
Bjerke SE; Vangen S; Holter E; Stray-Pedersen B
Scand J Public Health; 2011 Jul; 39(5):464-70. PubMed ID: 21339369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
